The vasodilator effects of A2AR may also lead to accelerate heart rate, and inhalation of adenosine in patients with asthma induces bronchoconstriction, which makes it contraindicated in patients with active asthma (Gao and Jacobson, 2017). The gene discussed is ADORA2A; the disease is asthma.